DRKS00023084已完成不适用
Enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccines in Belgium, Germany and Spain during the 2020/21 influenza season - 207750 (EPI-FLU-058 VS EUR)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,055
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6 Months 至 one（—）
- 性别
- All
入选标准
- •Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., complete the ADR card, return for the next scheduled visit or return the ADR card by mail in a timely manner using the pre-stamped envelope received at the site).
- •Written informed consent/informed assent obtained from the participants/participants’ parent(s)/Legally Acceptable Responsible(s) (LARs).
- •A male or female participant vaccinated with GSK’s quadrivalent seasonal influenza vaccine (one or two dose schedule) according to the routine country-specific medical practices between 01 October 2020 and 31 December 2020.
- •Participants aged 6 months and above at the time of the vaccination according to the countries’ specificities.
排除标准
- •The following criterion should be checked at the time of study entry. If the exclusion criterion applies, the participant must not be included in the study:
- •Child in care
研究者
相似试验
已完成
4 期
Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza SeasonInfluenza, HumanNCT03688620GlaxoSmithKline1,060
招募中
Unknown
To conduct survey of safety of Gadolinium-based substance used to improve the visibility of internal body structures in Magnetic Resonance Imaging (MRI) in IndiaCTRI/2024/04/066403Bayer Pharmaceuticals Pvt Ltd
已完成
4 期
Pharmacovigilance-VALERGEN-AsthmaAsthmaAsthma.Bronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000231ational Center of Bioproducts (BIOCEN)2,108
招募中
不适用
Monitoring of the safety and the performance of the Endoscopic Cap electrode (ECE50)J38Diseases of vocal cords and larynx, not elsewhere classifiedDRKS00027395MED-EL Elektromedizinische Geräte GmbH100
进行中（未招募）
1 期
An observational, safety follow-up extension to studies 2203 and 2203E1 to assess the safety of AAE581 in postmenopausal women with osteopenia/osteoporosisOsteoporosisEUCTR2007-002243-25-SKovartis Pharma Services AG675